Wealth Growth Daily

Health

China hotels, travel bookings perk up in boon for COVID-hit services sector

BY Reuters  • January 8, 2023January 8, 2023
(This Jan. 6 story has been corrected to fix the final paragraph to say 2 billion trips to be made, not 2 billion people to travel) By Joe Cash and Ellen Zhang BEIJING (Reuters) – After three ye[...]
Read more
Asia Business Economy Entertainment and Lifestyle Health

Eisai, Biogen get U.S. FDA approval for Alzheimer’s drug, apply for full approval

BY Reuters  • January 7, 2023January 7, 2023
By Julie Steenhuysen and Deena Beasley (Reuters) -The U.S. Food and Drug Administration on Friday approved the Alzheimer’s drug lecanemab developed by Eisai Co Ltd and Biogen Inc for patients in[...]
Read more
Business Health Top News Updated

Hermes expands in Nanjing as luxury industry bets on Chinese return

BY Reuters  • January 6, 2023January 6, 2023
By Mimosa Spencer PARIS (Reuters) – Birkin bag maker Hermes is opening a new, enlarged store in China’s Nanjing city, signalling the luxury industry’s confidence in a strong return o[...]
Read more
Asia Business Economy Europe Health

Surging recovery bets on China stocks face reality check

BY Reuters  • January 6, 2023January 6, 2023
By Jason Xue and Tom Westbrook SHANGHAI/SINGAPORE (Reuters) – Chinese investors are doubling down on economic recovery bets, with a flurry of new fund launches this week riding on optimism about[...]
Read more
Asia Business Economy Health

China expects passenger traffic during Lunar New Year to double from 2022

BY Reuters  • January 6, 2023January 6, 2023
BEIJING (Reuters) – China expects the total number of passenger trips made by travellers by road, rail, water and flight during the upcoming Lunar New Year to reach 2.1 billion this year, double[...]
Read more
Asia Business Economy Health

Moderna signs $35 million deal with cancer drug developer CytomX

BY Reuters  • January 5, 2023January 6, 2023
(Reuters) – Moderna Inc on Thursday announced a $35 million licensing deal with cancer-focused drug developer CytomX Therapeutics to work on messenger RNA-based therapies for a wide range of dis[...]
Read more
Business Economy Health Science US

Walgreens to pause M&A deals, focus on healthcare pivot

BY Reuters  • January 5, 2023January 5, 2023
By Raghav Mahobe and Aditya Samal (Reuters) – Walgreens Boots Alliance said on Thursday it will not strike new deals in the short term after a spate of acquisitions in recent years, as it focuse[...]
Read more
Business Health Updated US

J&J’s consumer health unit Kenvue files for IPO, moving closer to spin-off

BY Reuters  • January 5, 2023January 5, 2023
(Reuters) -Johnson & Johnson’s consumer health unit Kenvue on Wednesday filed to be listed as an independent company, bringing the healthcare conglomerate a step closer to completing the big[...]
Read more
Business Health Updated US

Trader Joe’s is sued over lead, cadmium levels in dark chocolate

BY Reuters  • January 4, 2023January 4, 2023
By Jonathan Stempel NEW YORK (Reuters) – Trader Joe’s was sued on Wednesday by a consumer who accused the grocery chain of misleading and endangering shoppers by selling dark chocolate tha[...]
Read more
Business Health US
« Previous 1 … 42 43 44 45 46 … 52 Next »
Wealth Growth Daily
PRIVACY POLICY

Copyright © 2026 Wealth Growth Daily. All Rights Reserved.

HIGH RISK WARNING

Trading foreign exchange, stocks, options, or futures on margin carries a high level of risk, and may not be suitable for all investors. Before deciding to trade, you should carefully consider your objectives, financial situation, needs and level of experience. Wealth Growth Daily provides general advice that does not take into account your objectives, financial situation or needs. The content of this website must not be construed as personal advice. The possibility exists that you could sustain a loss in excess of your deposited funds and therefore, you should not speculate with capital that you cannot afford to lose. You should be aware of all the risks associated with trading on margin. You should seek advice from an independent financial advisor. Past performance is not necessarily indicative of future success.

101 Marketside Ave. Suite 404 PMB 318 Ponte Vedra, FL 32081 | (321) 325-1551